SCHEMBL19132152

SCHEMBL19132152

c1ccc(-n2c3ccccc3c3ccc(-c4ccc5c(c4)c4cc6c7ccccc7c7ccccc7c6cc4n5-c4ccccc4)cc32)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.56
KDM4E B2RXH2 2/20 0.56
ATM Q13315 1/20 0.56
PTGER4 P35408 1/20 0.37
KMT2A Q03164 3/20 0.37
IL1R1 P14778 1/20 0.37
MAPK1 P28482 1/20 0.37
TSPO P30536 1/20 0.36
HDAC4 P56524 1/20 0.36
MEN1 O00255 2/20 0.36
ALDH1A1 P00352 2/20 0.36
MAPT P10636 1/20 0.36
HTT P42858 1/20 0.36
RXRA P19793 1/20 0.36
RXRB P28702 1/20 0.36
MAPK8 P45983 2/20 0.34
MAPK9 P45984 1/20 0.33
KDR P35968 1/20 0.33
PGR P06401 1/20 0.33
JAK2 O60674 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17736886 0.98 L3MBTL1 (0.58) L3MBTL1KDM4EATMPTGER4KMT2A
SCHEMBL15959722 0.98 L3MBTL1 (0.58) L3MBTL1KDM4EATMPTGER4KMT2A
SCHEMBL14728153 0.98 L3MBTL1 (0.58) L3MBTL1KDM4EATMPTGER4KMT2A
SCHEMBL17736881 0.97 L3MBTL1 (0.56) L3MBTL1KDM4EATMPTGER4KMT2A
SCHEMBL17736897 0.97 L3MBTL1 (0.56) L3MBTL1KDM4EATMPTGER4KMT2A
SCHEMBL23370423 0.97 L3MBTL1 (0.60) L3MBTL1KDM4EATMPTGER4KMT2A
SCHEMBL19132348 0.97 L3MBTL1 (0.60) L3MBTL1KDM4EATMPTGER4KMT2A
SCHEMBL16076370 0.97 L3MBTL1 (0.60) L3MBTL1KDM4EATMPTGER4KMT2A
SCHEMBL23370546 0.97 L3MBTL1 (0.60) L3MBTL1KDM4EATMPTGER4KMT2A
SCHEMBL14728135 0.95 L3MBTL1 (0.55) L3MBTL1KDM4EATMPTGER4KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11075343-B2 Organic light emitting compounds and organic light emitting devices including the same SFC CO., LTD. (KR) 2021-07-27 US disclosed
US-20170207397-A1 ORGANIC LIGHT EMITTING COMPOUNDS AND ORGANIC LIGHT EMITTING DEVICES INCLUDING THE SAME SFC CO., LTD. (KR) 2017-07-20 US disclosed
US-20170207397-A1 ORGANIC LIGHT EMITTING COMPOUNDS AND ORGANIC LIGHT EMITTING DEVICES INCLUDING THE SAME SFC CO., LTD. (KR) 2017-07-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11075343-B2 Organic light emitting compounds and organic light emitting devices including the same HARS1, ALDH1A2, NR2E3 L3MBTL1 562/4885KDM4E 3813/4885ATM 4125/4885
US-20170207397-A1 ORGANIC LIGHT EMITTING COMPOUNDS AND ORGANIC LIGHT EMITTING DEVICES INCLUDING THE SAME HARS1, ALDH1A2, ALDH1A3 L3MBTL1 451/4885KDM4E 3906/4885ATM 4456/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.